{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2010"],"data_sharing_plan":["IPD Sharing (as of September 2017): No"],"condition":["Adenomatous Polyposis Coli","Colorectal Neoplasms","Familial Adenomatous Polyposis","Nasopharyngeal Neoplasms"],"disease":["Adenomatous Polyposis Coli","Colorectal Neoplasms","Familial Adenomatous Polyposis","Nasopharyngeal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2052587"],"location":["Puerto Rico","United States"],"study_start_month":["10"],"keyword":["Curcumin"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Curcumin in Treating Patients With Familial Adenomatous Polyposis","description":"This randomized phase II trial studies curcumin in treating patients with familial adenomatous polyposis. Curcumin may prevent colorectal cancer in patients with a history of rectal polyps or colorectal neoplasia.","dates":{"creation":"2010-10-15"},"accession":"2052587","cross_references":{"ClinicalTrials___gov":["NCT00641147"]}}